Hospitals

Manage Transitions of Care from Admissions to Post-Discharge with the Next-Generation of Olio

Olio, a leading healthcare software company, announces continued investment for Skilled Nursing Operators to support transitions of care by reducing…

6 days ago

iScribeHealth Selected as AI Scribing Partner for Lifepoint Health Physicians

NASHVILLE, Tenn., Jan. 7, 2026 /PRNewswire/ -- iScribeHealth, a leading healthcare technology company specializing in ambient AI and mobile-first documentation…

6 days ago

iScribeHealth Selected as AI Scribing Partner for Lifepoint Health Physicians

NASHVILLE, Tenn., Jan. 7, 2026 /PRNewswire/ -- iScribeHealth, a leading healthcare technology company specializing in ambient AI and mobile-first documentation…

6 days ago

Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam

NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a…

6 days ago

iScribeHealth Selected as AI Scribing Partner for Lifepoint Health Physicians

NASHVILLE, Tenn., Jan. 7, 2026 /PRNewswire/ -- iScribeHealth, a leading healthcare technology company specializing in ambient AI and mobile-first documentation…

6 days ago

Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam

NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a…

6 days ago

Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam

NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a…

6 days ago

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The…

6 days ago

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The…

6 days ago

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The…

6 days ago